ZBTB1 inhibitors belong to a diverse class of chemical compounds that have demonstrated the ability to modulate the activity of the Zinc Finger and BTB Domain-Containing Protein 1 (ZBTB1), a transcriptional repressor. These inhibitors are primarily characterized by their capacity to interfere with the regulatory functions of ZBTB1 in gene expression processes. ZBTB1 is a member of the BTB-ZF (Broad Complex, Tramtrack, and Bric-a-Brac-Zinc Finger) family of transcription factors, known for their role in controlling various cellular processes, including cell proliferation, differentiation, and immune response regulation. ZBTB1, in particular, exerts its influence on gene transcription by binding to specific DNA sequences and recruiting co-repressors, such as histone deacetylases (HDACs), to inhibit gene expression.
Chemically, ZBTB1 inhibitors encompass a wide range of compounds, including small molecules, natural products, and synthetic agents. Some of these inhibitors are designed to directly bind to ZBTB1 protein, disrupting its interaction with DNA or co-repressors. Others may act indirectly by affecting the epigenetic landscape, modifying histone acetylation patterns, and subsequently altering the accessibility of DNA for transcription. Additionally, some compounds within this class may target upstream or downstream components of signaling pathways that intersect with ZBTB1-mediated processes. The mechanisms of action can vary considerably, reflecting the diverse chemical structures and properties of ZBTB1 inhibitors.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PRT4165 | 31083-55-3 | sc-507487 | 10 mg | $134.00 | ||
Inhibition of ZBTB1 transcriptional repressor | ||||||
2-Hydroxypropyl-β-cyclodextrin | 128446-35-5 | sc-203461 sc-203461B sc-203461C sc-203461A | 1 g 100 g 500 g 5 g | $53.00 $620.00 $1989.00 $133.00 | 8 | |
Potential ZBTB1 inhibition for multiple myeloma | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Inhibition of p53-MDM2 interaction and ZBTB1 | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
BET bromodomain inhibition, some ZBTB1 activity | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Potential ZBTB1 inhibition, anticancer properties | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Potential ZBTB1 inhibition, anti-cancer activity | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibition, epigenetic regulation | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
HDAC inhibition, epigenetic regulation | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Modulation of ZBTB1 expression in leukemia cells | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Potential ZBTB1 inhibition, anti-cancer activity | ||||||